Institut Mutualiste Montsouris
imm.frTotal trials
36
Active
4
Phase 3
2
Total enrollment
10,630
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Anorexia Nervosa6
- Prostate Cancer4
- Cancer3
- Atrial Fibrillation2
- Immune Checkpoint Inhibitor2
- Prostatic Neoplasms1
- Polyneuropathy, Critical Illness1
- Family Members1
Frequently asked questions about Institut Mutualiste Montsouris
- How many clinical trials does Institut Mutualiste Montsouris have on ClinicalTrials.gov?
- Institut Mutualiste Montsouris is listed as the lead sponsor on 36 clinical trials in ClinicalTrials.gov, 4 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Institut Mutualiste Montsouris's trials are in Phase 3?
- 2 of Institut Mutualiste Montsouris's trials are in Phase 3.
- What therapeutic areas does Institut Mutualiste Montsouris focus on?
- Institut Mutualiste Montsouris's most-studied conditions on ClinicalTrials.gov are Anorexia Nervosa, Prostate Cancer, Cancer, Atrial Fibrillation, Immune Checkpoint Inhibitor.